Biological activity of new aza analogues of quinolones
- 59 Downloads
- 7 Citations
Abstract
A series of novel derivatives of 4H-pyrido[1,2-a]pyrimidine, 1,4-dihydro-4-oxo-1,5-naphthyridine and 1,4-dihydro-4-oxo-1,6-naphthyridine were prepared and their biological activity was compared with that of nalidixic acid. Thein vitro antibacterial activity of the tested compounds was lower than that of nalidixic acid except for two agents,1b and2c, with a higher activity againstEnterococcus faecalis. The compounds were tested for their ability to cure four plasmids from two species ofEnterobacteriaceae. The derivatives eliminated three plasmids (pKM101, pBR322, F'lac) at one-half or one-quarter of the minimal inhibitory concentration. Plasmid RP4 was unaffected by the treatment. None of these compounds showed better antichloroplast activity than nalidixic acid.
Keywords
Quinolones Nalidixic Acid Oxolinic Acid Cinoxacin Pipemidic AcidPreview
Unable to display preview. Download preview PDF.
References
- Čejka K.J., Holubová I., Hubáček J.: Curing effect of clorobiocin onEscherichia coli plasmidsMol. Gen. Genet.186, 153–155 (198lesher2).Google Scholar
- Chabbert Y.A., Baudens J.G., Bouanchaud D.H.: Medical aspects of transferable drug resistance, pp. 227–239 in G.E.W. Wolstenholme, M. Oconnor (Eds):Ciba Foundation Symposium on Bacterial Episomes and Plasmids Churchill, London 1969.Google Scholar
- Cramer M., Myers J.: Growth and photosyntetic characteristics onEuglena gracilis.Arch. Mikrobiol.17, 384–402 (1952).CrossRefGoogle Scholar
- Hahn F.E., Ciak J.: Elimination of resistance determinants from R-factor R1 by intercalative compounds.Antimicrob. Agents Chemother.9, 77–80 (1976).PubMedGoogle Scholar
- Danilevskaya O.N., Gragerov A.I.: Curing ofEscherichia coli K12 by coumermycin.Mol. Gen. Genet.178, 233–235 (1980).PubMedCrossRefGoogle Scholar
- Ilavský D., Abaffyová V., Bobošík V.: Gould-Jacobson reaction of aminopyridines.Coll. Czech. Chem. Commun.00, 000–000 (1997).Google Scholar
- Hooper D.C., Wolfson J.S., McHugh G.L., Swartz M.D., Tung C., Swartz M.N.: Elimination of plasmid pMG110 fromEscherichia coli by novobiocin and other inhibitors of DNA gyrase.Antimicrob. Agents Chemother.25, 586–590 (1984).PubMedGoogle Scholar
- Hooper D.C., Wolfson J.S.: Fluoroquinolone antimicrobial agents.N. Engl. J. Med.324, 384–394 (1991).PubMedCrossRefGoogle Scholar
- Krajčovič J., Ebringer L., Polónyi J.: Quinolones and coumarins eliminate chloroplast fromEuglena gracilis.Antimicrob. Agents Chemother.33, 1883–1889 (1989).PubMedGoogle Scholar
- Krčméry V.:the Modern Pharmacotherapeutics Vol. VI. Quinolones, (In Slovak) Osveta, Martin 1992.Google Scholar
- Lesher G.Y., Froelich E.J., Gruett M.D., Bailey J.H., Brundage R.P.: 8-Naphthyridine derivatives—a new class of chemotherapeutic agents.J. Med. Pharm. Chem.5, 1063 (1962).CrossRefGoogle Scholar
- Ruxer J.M., Lachoux C., Ousset J.B., Torregrosa J.L., Mattioda G.: Synthesis of 1,4-dihydro-4-oxopyrrolo[1,2-b]pyridazine-3-carboxylic acids and 1,4-dihydro-4-oxoimidazo[1,5-b]pyrazine-3-carboxylic acid as potential antibacterial agents.J. Heterocycl. Chem.31, 409–417 (1994).CrossRefGoogle Scholar